Laroche J P, Becker F, Baud J M, Miserey G, Jaussent A, Picot M C, Bura-Rivière A, Quéré I
Médecine interne et médecine vasculaire, hôpital Saint-Éloi, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.
40, chemin des Favrands, 74400 Chamonix-Mont-Blanc, France.
J Mal Vasc. 2015 Dec;40(6):340-9. doi: 10.1016/j.jmv.2015.07.104. Epub 2015 Sep 12.
Although aneurysm of the abdominal infra-renal aorta (AAA) meets criteria warranting B mode ultrasound screening, the advantages of mass screening versus selective targeted opportunistic screening remain a subject of debate. In France, the French Society of Vascular Medicine (SFMV) and the Health Authority (HAS) published recommendations for targeted opportunistic screening in 2006 and 2013 respectively. The SFMV held a mainstream communication day on November 21, 2013 in France involving participants from metropolitan France and overseas departments that led to a proposal for free AAA ultrasound screening: the Vesalius operation. Being a consumer operation, the selection criteria were limited to age (men and women between 60 and 75 years); the age limit was lowered to 50 years in case of direct family history of AAA. More than 7000 people (as many women as men) were screened in 83 centers with a 1.70% prevalence of AAA in the age-based target population (3.12% for men, 0.27% for women). The median diameter of detected AAA was 33 mm (range 20 to 74 mm). The prevalence of AAA was 1.7% in this population. Vesalius data are consistent with those of the literature both in terms of prevalence and for cardiovascular risk factors with the important role of smoking. Lessons from Vesalius to take into consideration are: screening is warranted in men 60 years and over, especially smokers, and in female smokers. Screening beyond 75 years should be discussed. Given the importance of screening, the SFMV set up a year of national screening for AAA (Vesalius operation 2014/2015) in order to increase public and physician awareness about AAA detection, therapeutic management, and monitoring. AAA is a serious, common, disease that kills 6000 people each year. The goal of screening is cost-effective reduction in the death toll.
尽管腹主动脉肾下段动脉瘤(AAA)符合B型超声筛查标准,但群体筛查与选择性目标机会性筛查相比的优势仍是一个有争议的话题。在法国,法国血管医学协会(SFMV)和卫生当局(HAS)分别于2006年和2013年发布了目标机会性筛查的建议。SFMV于2013年11月21日在法国举办了一次主流宣传日活动,来自法国本土和海外部门的参与者参加了此次活动,活动促成了一项免费AAA超声筛查提案:维萨里乌斯行动。作为一项面向消费者的行动,选择标准仅限于年龄(60至75岁的男性和女性);如果有AAA家族史,年龄限制可降至50岁。83个中心对7000多人(男女数量相同)进行了筛查,在基于年龄的目标人群中AAA患病率为1.70%(男性为3.12%,女性为0.27%)。检测到的AAA的中位直径为33毫米(范围为20至74毫米)。该人群中AAA的患病率为1.7%。维萨里乌斯行动的数据在患病率以及心血管危险因素方面与文献数据一致,吸烟起到了重要作用。维萨里乌斯行动的经验教训值得考虑:60岁及以上的男性,尤其是吸烟者,以及女性吸烟者有必要进行筛查。75岁以上人群的筛查需要进一步讨论。鉴于筛查的重要性,SFMV开展了为期一年的全国AAA筛查(2014/2015年维萨里乌斯行动),以提高公众和医生对AAA检测、治疗管理及监测的认识。AAA是一种严重且常见的疾病,每年导致6000人死亡。筛查的目标是通过成本效益降低死亡人数。